You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,358,235


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,358,235 protect, and when does it expire?

Patent 9,358,235 protects TURALIO and is included in one NDA.

This patent has twenty-two patent family members in fifteen countries.

Summary for Patent: 9,358,235
Title:Kinase modulation, and indications therefor
Abstract: The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof.
Inventor(s): Bollag; Gideon (Hercules, CA), Hirth; Klaus-Peter (San Francisco, CA), Ibrahim; Prabha N. (Mountain View, CA), Lin; Paul (Oakland, CA), West; Brian (San Francisco, CA)
Assignee: Plexxikon Inc. (Berkeley, CA)
Application Number:13/802,106
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,358,235: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 9,358,235, focusing on its scope, claims, and the broader patent landscape.

Overview of United States Patent 9,358,235

Patent Title and Abstract

United States Patent 9,358,235, titled "Kinase modulation, and indications therefor," pertains to methods of using protein kinase inhibitors for treating various diseases and conditions. The patent abstract outlines the use of these inhibitors in therapeutic applications, highlighting their potential in medical treatments[4].

Scope of the Patent

Technical Field

The patent falls within the technical field of biochemistry and pharmacology, specifically focusing on kinase modulation. Kinases are enzymes that play critical roles in cellular signaling pathways, and their dysregulation is often associated with various diseases, including cancer and inflammatory disorders.

Background of the Invention

The background section of the patent discusses the importance of kinases in cellular processes and the need for effective inhibitors to treat kinase-related diseases. It also reviews existing kinase inhibitors and their limitations, setting the stage for the novel approach described in the patent.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the composition of the kinase inhibitors, the methods of using these inhibitors, and the specific diseases or conditions they are intended to treat. For example, Claim 1 might describe a specific compound or class of compounds that inhibit a particular kinase, while Claim 2 might outline a method of administering these compounds for therapeutic purposes[4].

Dependent Claims

Dependent claims further narrow the scope of the independent claims by adding additional limitations or specifications. These claims often provide more detailed descriptions of the compounds, their synthesis, or the specific conditions under which they are effective.

Patent Landscape Analysis

Understanding Patent Landscape Analysis

Patent landscape analysis, also known as patent mapping, is a process that analyzes, organizes, and extracts value from vast amounts of patent data. This analysis can provide insights into competitors, market trends, and the legal status of patents in a particular field[3].

Application to US Patent 9,358,235

For US Patent 9,358,235, a patent landscape analysis would involve identifying other patents related to kinase inhibitors, understanding the legal status of these patents (e.g., pending, granted, expired), and analyzing trends in kinase modulation research. This analysis can help in identifying potential competitors, understanding market developments such as mergers and acquisitions, and assessing litigation risks.

Key Elements of Patent Landscape Analysis

  • Application Number, Filing Date, and Country: These details help in tracking the patent's history and its global presence.
  • Legal Status: Knowing whether a patent is alive, pending, lapsed, revoked, or expired is crucial for strategic decision-making.
  • Expected Expiry Dates: This information is vital for planning future research and development activities.
  • Patent Trends and Market Developments: Analyzing charts and reports can reveal critical insights into market dynamics and business risks[3].

Global Patent Family

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. For US Patent 9,358,235, this service can help in identifying other patents within the same patent family, including those filed in different countries and languages[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This tool is useful for visualizing the search results for the same invention produced by several offices on a single page, which can be particularly relevant for understanding the global patent landscape of kinase inhibitors[1].

Legal and Business Implications

Litigation and Opposition Activities

Patent landscape analysis can reveal litigation and opposition activities related to kinase inhibitors. This information is crucial for assessing the legal risks associated with developing or using similar technologies.

Licensing and Collaboration

Understanding the patent landscape can also identify opportunities for in-licensing or out-licensing of kinase inhibitor technologies. This can be a strategic move to expand a company's portfolio or to collaborate with other entities in the field[3].

Conducting a Preliminary Patent Search

Resources Available

To conduct a preliminary patent search related to US Patent 9,358,235, several resources are available:

  • Patent Public Search: A powerful and flexible tool that replaced legacy search tools like PubEast and PubWest[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers provide local search resources and training in patent search techniques[1].
  • Public Search Facility: Located in Alexandria, VA, this facility offers access to patent and trademark information in various formats[1].

Conclusion

Understanding the scope and claims of US Patent 9,358,235 is essential for anyone involved in kinase modulation research or the development of related therapeutic treatments. By conducting a thorough patent landscape analysis and utilizing the resources provided by the USPTO, one can gain valuable insights into the legal, business, and technical aspects of this field.

Key Takeaways

  • Patent Scope: The patent focuses on methods of using protein kinase inhibitors for treating diseases.
  • Claims: Independent and dependent claims define the composition and use of these inhibitors.
  • Patent Landscape: Analysis reveals competitors, market trends, and legal status of related patents.
  • Global Patent Family: Tools like Global Dossier and CCD help in understanding the global presence of related patents.
  • Legal and Business Implications: Understanding litigation, licensing, and collaboration opportunities is crucial.

FAQs

What is the main focus of US Patent 9,358,235?

The main focus of US Patent 9,358,235 is on methods of using protein kinase inhibitors for treating various diseases and conditions.

How can I conduct a patent landscape analysis for kinase inhibitors?

You can conduct a patent landscape analysis by using tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD), and by analyzing reports and charts that provide insights into competitors, market trends, and legal status.

What are the key elements of a patent landscape analysis?

Key elements include application number, filing date, country, legal status, expected expiry dates, patent trends, and market developments.

How can I identify potential competitors in the kinase inhibitor field?

By analyzing patent landscape reports and using tools like the Global Dossier and CCD, you can identify other patents and applications related to kinase inhibitors, which can help in identifying potential competitors.

What resources are available for conducting a preliminary patent search?

Resources include the USPTO's Patent Public Search, Patent and Trademark Resource Centers (PTRCs), and the Public Search Facility in Alexandria, VA.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. Sagacious Research - Navigating Technological Domains with Patent Landscape Analysis. Retrieved from https://sagaciousresearch.com/blog/navigating-technological-domains-with-patent-landscape-analysis/
  4. Google Patents - US9358235B2 - Kinase modulation, and indications therefor. Retrieved from https://patents.google.com/patent/US9358235B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,358,235

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-002 Oct 14, 2022 RX Yes No 9,358,235 ⤷  Subscribe TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT) ASSOCIATED WITH SEVERE MORBIDITY OR FUNCTIONAL LIMITATIONS AND NOT AMENABLE TO IMPROVEMENT WITH SURGERY ⤷  Subscribe
Daiichi Sankyo Inc TURALIO pexidartinib hydrochloride CAPSULE;ORAL 211810-001 Aug 2, 2019 DISCN Yes No 9,358,235 ⤷  Subscribe TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC TENOSYNOVIAL GIANT CELL TUMOR (TGCT) ASSOCIATED WITH SEVERE MORBIDITY OR FUNCTIONAL LIMITATIONS AND NOT AMENABLE TO IMPROVEMENT WITH SURGERY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,358,235

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013235298 ⤷  Subscribe
Australia 2017254821 ⤷  Subscribe
Brazil 112014023162 ⤷  Subscribe
Canada 2867918 ⤷  Subscribe
China 104703623 ⤷  Subscribe
Eurasian Patent Organization 029676 ⤷  Subscribe
Eurasian Patent Organization 201491721 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.